Cell therapies often encounter issues with patient safety due to Microbial Contamination. Traditional growth QCs prevent release testing prior to treatment for allogenic and autologous therapies. Discover the 3-hour PCR-based microbial tests; Enabling both rapid release testing and process \control you can ensure patient safety within your workflow.